Publikationen in Zusammenarbeit mit Forschern von Centro Nacional de Microbiología (22)

2024

  1. A Phase I/IIa Prospective, Randomized, Open-Label Study on the Safety and Efficacy of Nebulized Liposomal Amphotericin for Invasive Pulmonary Aspergillosis

    Journal of Fungi, Vol. 10, Núm. 3

2023

  1. Breakthrough invasive fungal infection among patients with haematologic malignancies: A national, prospective, and multicentre study

    Journal of Infection, Vol. 87, Núm. 1, pp. 46-53

2021

  1. Do high MICs predict the outcome in invasive fusariosis?

    The Journal of antimicrobial chemotherapy, Vol. 76, Núm. 4, pp. 1063-1069

  2. Invasive fusariosis in nonneutropenic patients, Spain, 2000-2015

    Emerging Infectious Diseases, Vol. 27, Núm. 1, pp. 26-35

2020

  1. Effect of Influenza Vaccination Inducing Antibody Mediated Rejection in Solid Organ Transplant Recipients

    Frontiers in Immunology, Vol. 11

  2. Pharmacokinetics of echinocandins in suspected candida peritonitis: A potential risk for resistance

    International Journal of Infectious Diseases, Vol. 101, pp. 24-28

2019

  1. Executive summary of clinical practice guideline for the management of invasive diseases caused by Aspergillus: 2018 Update by the GEMICOMED-SEIMC/REIPI

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 37, Núm. 8, pp. 535-541

2017

  1. Evaluation of the possible influence of trailing and paradoxical effects on the clinical outcome of patients with candidemia

    Clinical Microbiology and Infection, Vol. 23, Núm. 1, pp. 49.e1-49.e8

  2. Impact of fluconazole susceptibility on the outcome of patients with candidaemia: data from a population-based surveillance

    Clinical Microbiology and Infection, Vol. 23, Núm. 9, pp. 672.e1-672.e11

2016

  1. Empirical and targeted therapy of candidemia with fluconazole versus echinocandins: a propensity score–derived analysis of a population-based, multicentre prospective cohort

    Clinical Microbiology and Infection, Vol. 22, Núm. 8, pp. 733.e1-733.e8

2015

  1. A simple prediction score for estimating the risk of candidaemia caused by fluconazole non-susceptible strains

    Clinical Microbiology and Infection, Vol. 21, Núm. 7, pp. 684.e1-684.e9

  2. Candida tropicalis bloodstream infection: Incidence, risk factors and outcome in a population-based surveillance

    Journal of Infection, Vol. 71, Núm. 3, pp. 385-394

  3. Epidemiology and outcome of candidaemia in patients with oncological and haematological malignancies: RESULTS from a population-based surveillance in Spain

    Clinical Microbiology and Infection, Vol. 21, Núm. 5, pp. 491.e1-491.e10

2014

  1. Clinical validation of a multiplex real-time PCR assay for detection of invasive candidiasis in intensive care unit patients

    Journal of Antimicrobial Chemotherapy, Vol. 69, Núm. 11, pp. 3134-3141

  2. Epidemiology and predictive factors for early and late mortality in Candida bloodstream infections: A population-based surveillance in Spain

    Clinical Microbiology and Infection, Vol. 20, Núm. 4

  3. Invasive fungal infections in solid organ transplant recipients

    Clinical Microbiology and Infection, Vol. 20, Núm. s7, pp. 27-48

2012

  1. Fungal infection in solid organ recipients

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 30, Núm. SUPPL.2, pp. 49-56

2011

  1. Guidelines for the treatment of invasive candidiasis and other yeasts. Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC). 2010 Update

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 29, Núm. 5, pp. 345-361

  2. Guidelines for the treatment of invasive fungal disease by Aspergillus spp. and other fungi issued by the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC). 2011 Update

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 29, Núm. 6, pp. 435-454

  3. Spanish Society of Clinical Microbiology and Infectious Diseases (SEIMC) guidelines for the diagnosis of invasive fungal infections. 2010 Update

    Enfermedades Infecciosas y Microbiologia Clinica